Evaluating Market Demand and Revenue Generation in the Electroceuticals Market Sector
The market for electroceuticals was valued at USD 23.30 billion in 2022 and is anticipated to grow at a 5.6% CAGR in terms of revenue during the projected period. The rising incidence of cardiovascular and neurological diseases is a major driver fueling market revenue growth. Worldwide, cardiovascular illnesses, such as heart disease and stroke, claim the lives of over 18.6 million people each year, according to the International Heart Federation. More than 75% of these fatalities take place in low- and middle-income nations. Rheumatic fever usually affects children in underdeveloped nations, especially when poverty is pervasive. In the entire world, rheumatic heart disease is responsible for around 2% of cardiovascular disease-related deaths. The incidence of neurological conditions like Parkinson's disease is also contributing to the rise in market revenue. More than 10 million people globally, including about one million Americans, are expected to be afflicted by Parkinson...